Scientific discoveries and technological breakthroughs have
now made it possible to look at cancer more closely at a
molecular level. Target Now utilizes an advanced molecular
profiling analysis to provide a more detailed molecular ‘blueprint’of your tumor to your physician.
Through advanced DNA, RNA and protein analysis, Target
Now typically identifies multiple unique genes, gene expressions
and proteins in your tumor. Additionally, Target Now
provides information on associated drugs, including nonstandard-of-care associations, that may potentially have
greater efficacy or be resistant if these targets are present
based on research publications and clinical studies. It is up
to your physician to determine your appropriate treatment
regimen.
Target Now testing provides information that may help your
physician when considering potential treatment options.
Some of these treatment options may include new drugs
called targeted therapeutics or monoclonal antibody (MAb)
treatments. These are therapies that may be directed at
one or more of the identified gene and protein‘targets’or ‘markers’ that may be identified by Target Now. Some of
these agents may be available only through clinical trials.
Target Now can be performed on any cancer type, including
solid or non-solid tumors. Target Now may be most useful
for cancer patients when standard-of-care treatments are ineffective or are not available. Even if you may have already
received treatment for your cancer, you can still have the
test performed. However, your doctor should decide when
to order the test.
Target Now tumor testing may include several analytical
technologies, but primarily utilizes a panel of DNA microarray
analysis and immunohistochemistry (IHC). DNA microarray
analysis looks at which genes (DNA) are working or not in
the unique cancer being analyzed. IHC detects specific
proteins (part of the cancer’s infrastructure) unique to a
patient’s tumor cells. In some cases, Target Now testing may
also include fluorescent in-situ hybridization (FISH) and
gene sequencing.
These tests are summarized and integrated into a single
report to help create a more detailed molecular ‘blueprint’
of your tumor for your physician. The report provides information
for use by your treating doctor that, along with their
clinical judgment,may help them with your treatment plan.
Results are sent directly to your physician.
No, a ‘diagnostic’ test determines whether someone may
have a particular disease or medical condition. Target Now
testing is typically performed once your doctor has already
confirmed or diagnosed that you have some form of cancer.
No, these are called‘prognostic’ tests. Prognostic tests help
your doctor determine if you or a family member are at risk for developing a particular condition or cancer, or if there
is a risk that there could be a recurrence or aggressive form
of a disease or cancer. For example, the test that detects a
woman’s risk, or her female family member’s risk, of developing
breast or ovarian cancer by looking at changes in
two genes (the BRCA1 and BRCA2 genes) is one of these
tests. Rather, the Target Now test provides additional molecular
information to potentially assist your doctor in the
management of your cancer.
Target Now is performed on tissue that is obtained during
the surgical removal of your tumor (biopsy or excision) or
from a sample collected during a bone marrow aspirate
biopsy. Even if your doctor doesn’t feel a need to order
Target Now testing at this time, the hospital where your
biopsy was performed will typically store some of your tissue
as standard procedure. Now or in the future, your doctor
can request that Target Now testing be run and coordinate
with the hospital to have your sample sent to us.
Target Now testing is performed at the Caris Dx laboratory
located in Phoenix, Arizona. Caris Dx provides world-class
diagnostic services (anatomic pathology and molecular
diagnostics) nationwide to thousands of patients every week.
The laboratory is CLIA certified and staffed by licensed
technologists and physicians.
Once we receive your sample, the required forms and medical information, testing usually takes about five to ten working days. Your results will be provided directly to your physician for review and discussion with you.
The Target Now test is reimbursed by Medicare and other
insurance providers. Caris Dx will bill your insurance
company for Target Now testing and you may only be
responsible for the co-payments or deductibles that
we are required to bill by law.
Yes, as noted above, Caris Dx can work with you or your
doctor to get tissue from a previous biopsy or to have your fresh/frozen tissue stored appropriately for future
testing at our facility.Make sure that you ask your doctor
about having your tissue sent for storage even if he or
she decides that Target Now testing isn’t appropriate
for you today. This storage service is called the Horizon
Program.
Target Now Testing is only available to medical professionals
and cannot be ordered by patients. If you believe that you
qualify or would like to investigate the opportunity of having
Target Now testing performed, you should consult your treating
physician. The information contained in this brochure is not
intended as medical advice, and should not be relied upon
as a substitute for consultations with qualified health professionals
who are familiar with your individual medical needs.
This FAQ is provided by Caris Diagnostics as an educational service for physicians and their patients